Share
tweet
Aspen earnings rise as drug maker targets weight-loss market
Written on 02/09/2026
Janice Kew, Bloomberg
Share
tweet
Normalised earnings from continuing operations rose 28% at constant exchange rates in the year through June.
Read full article